BDNF Serum Concentrations Show No Relationship with Diagnostic Group or Medication Status in Neurodegenerative Disease

E-ISSN： 1875-5828|9|7|815-821

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.9, Iss.7, 2012-09, pp. : 815-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease

Current Alzheimer Research, Vol. 13, Iss. 6, 2016-06 ,pp. : 654-662

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 15-20

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Glutamine Synthetase Has No Value as a Diagnostic Biomarker for Alzheimer's Disease

By Vermeiren Yannick

Neurochemical Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 1858-1862

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Copper in Neurodegenerative Disease

By Waggoner D.J. Bartnikas T.B. Gitlin J.D.

Neurobiology of Disease, Vol. 6, Iss. 4, 1999-08 ,pp. : 221-230

Academic Press

Access to resources Recommend Favorite

Anosognosia in neurodegenerative disease

By Rosen Howard

Neurocase, Vol. 17, Iss. 3, 2011-06 ,pp. : 231-241

Routledge Ltd

Access to resources Recommend Favorite